196 related articles for article (PubMed ID: 18479261)
1. A gut feeling of the PXR, PPAR and NF-kappaB connection.
Wahli W
J Intern Med; 2008 Jun; 263(6):613-9. PubMed ID: 18479261
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB and cancer: mechanisms and targets.
Karin M
Mol Carcinog; 2006 Jun; 45(6):355-61. PubMed ID: 16673382
[TBL] [Abstract][Full Text] [Related]
3. Xenobiotic receptor meets NF-kappaB, a collision in the small bowel.
Xie W; Tian Y
Cell Metab; 2006 Sep; 4(3):177-8. PubMed ID: 16950133
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB signaling: pros and cons of altering NF-kappaB as a therapeutic approach.
Egan LJ; Toruner M
Ann N Y Acad Sci; 2006 Aug; 1072():114-22. PubMed ID: 17057194
[TBL] [Abstract][Full Text] [Related]
5. Nuclear factor-kappa B in intestinal protection and destruction.
Spehlmann ME; Eckmann L
Curr Opin Gastroenterol; 2009 Mar; 25(2):92-9. PubMed ID: 19528876
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of the processes of human labour and delivery.
Lappas M; Rice GE
Placenta; 2009 Mar; 30 Suppl A():S90-5. PubMed ID: 19010537
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of sulfasalazine effect in experimental colitis is consistent primarily with the modulation of NF-kappaB but not PPAR-gamma signaling.
Martínez-Augustin O; López-Posadas R; González R; Suárez MD; Zarzuelo A; Sánchez de Medina F
Pharmacogenet Genomics; 2009 May; 19(5):363-72. PubMed ID: 19365232
[TBL] [Abstract][Full Text] [Related]
8. Mutual repression between steroid and xenobiotic receptor and NF-kappaB signaling pathways links xenobiotic metabolism and inflammation.
Zhou C; Tabb MM; Nelson EL; Grün F; Verma S; Sadatrafiei A; Lin M; Mallick S; Forman BM; Thummel KE; Blumberg B
J Clin Invest; 2006 Aug; 116(8):2280-2289. PubMed ID: 16841097
[TBL] [Abstract][Full Text] [Related]
9. Role of NF-kappaB activation in intestinal immune homeostasis.
Wullaert A
Int J Med Microbiol; 2010 Jan; 300(1):49-56. PubMed ID: 19781989
[TBL] [Abstract][Full Text] [Related]
10. NF-kappaB in inflammatory bowel disease.
Atreya I; Atreya R; Neurath MF
J Intern Med; 2008 Jun; 263(6):591-6. PubMed ID: 18479258
[TBL] [Abstract][Full Text] [Related]
11. Nuclear receptors. I. PPAR gamma in the gastrointestinal tract: gain or pain?
Auwerx J
Am J Physiol Gastrointest Liver Physiol; 2002 Apr; 282(4):G581-5. PubMed ID: 11897616
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between nuclear receptors and nuclear factor kappaB.
De Bosscher K; Vanden Berghe W; Haegeman G
Oncogene; 2006 Oct; 25(51):6868-86. PubMed ID: 17072333
[TBL] [Abstract][Full Text] [Related]
13. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA.
Kelly D; Campbell JI; King TP; Grant G; Jansson EA; Coutts AG; Pettersson S; Conway S
Nat Immunol; 2004 Jan; 5(1):104-12. PubMed ID: 14691478
[TBL] [Abstract][Full Text] [Related]
14. Contradictory functions of NF-kappaB in liver physiology and cancer.
Vainer GW; Pikarsky E; Ben-Neriah Y
Cancer Lett; 2008 Aug; 267(2):182-8. PubMed ID: 18479806
[TBL] [Abstract][Full Text] [Related]
15. Reduced beta-catenin and peroxisome proliferator-activated receptor-gamma expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome.
Pancione M; Forte N; Sabatino L; Tomaselli E; Parente D; Febbraro A; Colantuoni V
Hum Pathol; 2009 May; 40(5):714-25. PubMed ID: 19121846
[TBL] [Abstract][Full Text] [Related]
16. G protein-coupled receptor connectivity to NF-kappaB in inflammation and cancer.
Fraser CC
Int Rev Immunol; 2008; 27(5):320-50. PubMed ID: 18853342
[TBL] [Abstract][Full Text] [Related]
17. NF-kappaB signaling pathway and its therapeutic implications in human diseases.
Sarkar FH; Li Y; Wang Z; Kong D
Int Rev Immunol; 2008; 27(5):293-319. PubMed ID: 18853341
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the TLR/NF-kappaB pathway in antigen-presenting cells in malignancies promoted by inflammation.
Blander JM
Methods Mol Biol; 2009; 512():99-117. PubMed ID: 19347275
[TBL] [Abstract][Full Text] [Related]
19. Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer.
Danese S; Mantovani A
Oncogene; 2010 Jun; 29(23):3313-23. PubMed ID: 20400974
[TBL] [Abstract][Full Text] [Related]
20. Roles of NF-kappaB in health and disease: mechanisms and therapeutic potential.
Wong ET; Tergaonkar V
Clin Sci (Lond); 2009 Mar; 116(6):451-65. PubMed ID: 19200055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
